Furthermore, promising NO-releasing drug MPC-1011 used in the rat hindlimb ischemia model of PAD (peripheral arterial disease) was shown to act in the NO/cGMP/VEGF-dependent way [79]. Here, VEGFA is linked to peripheral arterial disease.